MaxWell Biosystems

Description: MaxWell Biosystems develops tech for neuroscience research & drug development, featuring MaxOne, a high-density microelectrode array platform.

Country: Switzerland

Based in: Basel

Founded: 2016

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.